286 related articles for article (PubMed ID: 18812393)
1. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.
Ruffatti A; Del Ross T; Ciprian M; Nuzzo M; Rampudda M; Bertero MT; Bergia R; Caramaschi P; Biasi D; Capsoni F; Montaguti L; Ruffini R; Brucato A; Picillo U; Fanelli V; Riccieri V; Piccoli A; Valesini G; Doria A; Meroni PL; Tincani A
Ann Rheum Dis; 2009 Mar; 68(3):397-9. PubMed ID: 18812393
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study.
Ruffatti A; Del Ross T; Ciprian M; Bertero MT; Sciascia S; Scarpato S; Montecucco C; Rossi S; Caramaschi P; Biasi D; Doria A; Rampudda M; Monica N; Fischetti F; Picillo U; Brucato A; Salvan E; Vittorio P; Meroni P; Tincani A;
Ann Rheum Dis; 2011 Jun; 70(6):1083-6. PubMed ID: 21285115
[TBL] [Abstract][Full Text] [Related]
3. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
5. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW
Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
8. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
9. Persistency of low levels of anticardiolipin and anti-beta2 glycoprotein1 in thrombosis.
Amaral M; Favas C; Delgado Alves J
Eur J Intern Med; 2010 Apr; 21(2):101-3. PubMed ID: 20206880
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
13. Real world experience with antiphospholipid antibody tests: how stable are results over time?
Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD
Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
[TBL] [Abstract][Full Text] [Related]
14. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
[TBL] [Abstract][Full Text] [Related]
15. IgA antiphospholipid antibodies are an independent risk factor for thromboses.
Shen YM; Lee R; Frenkel E; Sarode R
Lupus; 2008 Nov; 17(11):996-1003. PubMed ID: 18852223
[TBL] [Abstract][Full Text] [Related]
16. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
17. Clinical consequences of antiphospholipid antibodies: an historic cohort study.
Silver RM; Draper ML; Scott JR; Lyon JL; Reading J; Branch DW
Obstet Gynecol; 1994 Mar; 83(3):372-7. PubMed ID: 8127528
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B
Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681
[TBL] [Abstract][Full Text] [Related]
19. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up].
Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA
Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]